Pyrimidine Nucleosides from Streptomyces sp. SSA28

Area of Science:

• Marine Natural Products Chemistry
• Medicinal Chemistry
• Microbial Metabolomics

Background:

• Marine-derived microorganisms, such as Streptomyces species, are a rich source of structurally diverse bioactive compounds.
• Pyrimidine nucleosides represent a class of compounds with significant therapeutic potential, including anticancer activities.
• The isolation and characterization of novel natural products are crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize new pyrimidine nucleosides from the marine-derived Streptomyces sp. SSA28.
• To evaluate the cytotoxic potential of the isolated compounds against human colon cancer cell lines.
• To determine the absolute configurations of novel compounds for structure-activity relationship studies.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation employing Nuclear Magnetic Resonance (NMR) spectroscopy and High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS).
• Determination of absolute configurations via X-ray diffraction and Electronic Circular Dichroism (ECD) calculations.

Main Results:

• Eleven new pyrimidine nucleosides (1-11) and twelve known analogues (12-23) were successfully isolated.
• The structures of new compounds were confirmed through comprehensive spectroscopic analyses.
• Compounds 11-16 exhibited notable cytotoxicity against HCT-116 human colon cancer cells, with IC50 values ranging from 0.39 to 6.63 μM.

Conclusions:

• The marine-derived Streptomyces sp. SSA28 produces novel pyrimidine nucleosides with significant cytotoxic activity.
• Compounds 11-16 represent promising leads for the development of new colon cancer therapeutics.
• Further investigation into the mechanism of action and structure-activity relationships is warranted.